Treatment for Patients With Non-Myeloid Malignancies Receiving Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Cancer
Related studies linked through entity extraction aliases.
Treatment for Subjects With Unresectable Stage III or Stage IV Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Study of Erbitux™ (Cetuximab) in Pediatric Patients With Refractory Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Caspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE2
An Extension Study to Evaluate Avastin in Patients Treated in a Previous Genentech-Sponsored Cancer Study
- Status
- COMPLETED
- Phase
- PHASE2
Palifermin for the Reduction of Oral Mucositis in Single-dose Evaluation (PROMISE)
- Status
- COMPLETED
- Phase
- PHASE3
Skin Incision Study - Closure of Skin Incisions in Gynecological Cancer Surgery
- Status
- COMPLETED
- Phase
- PHASE3
Low-risk Fever and Neutropenia in Children With Cancer: Safety and Efficacy of Oral Antibiotics in an Outpatient Setting
- Status
- TERMINATED
- Phase
- PHASE3
HOPE-2 Study (Heart Outcomes Prevention Evaluation-2 Study)
- Status
- UNKNOWN
- Phase
- PHASE4
Effectiveness of Narrative Medicine on Pain Intensity and Quality of Life
- Status
- COMPLETED
- Phase
- NA
OraVescent Fentanyl (OVF) for the Treatment of Breakthrough Pain in Opioid Tolerant Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE3
A Smoking, Alcohol, and Depression Intervention for Head and Neck Cancer
- Status
- COMPLETED
- Phase
- NA
Study to Evaluate MEDI-507 in Patients With CD2-Positive Lymphoma/Leukemia
- Status
- TERMINATED
- Phase
- PHASE1
Treatment of Breakthrough Pain in Opioid Tolerant Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE3
A Study of MK0731 in Patients With Advanced Solid Tumors (0731-002)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE1
Study of XL999 in Adults With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
RAV12 in Treating Patients With Metastatic or Recurrent Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE1
Pilot Study to Evaluate the Safety and Analgesic Activity of M40403 Co-Administered With an Opioid Agent for Cancer Pain
- Status
- TERMINATED
- Phase
- PHASE2
BAY43-9006 - Phase II Study in Non-Small Cell Lung Carcinoma (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Pharmacokinetics of Single Intravenous Doses of Peginesatide in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1